Use of Local Intraoperative Steroid in MIS TLIF
Effects of Intraoperative Local Steroid Utilization in a Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion
1 other identifier
interventional
105
0 countries
N/A
Brief Summary
The purpose of this study is to determine if the frequency and duration of postoperative pain are improved in participants receiving a local steroid injection (methylprednisolone) plus a systemic (intravenous (IV, by vein)) steroid (dexamethasone) when compared to those receiving a systemic (IV) steroid (dexamethasone) alone. Both of these steroid injections are already currently used at Rush and are considered standard of practice. It is well established that steroids have an anti-inflammatory (decreased swelling) effect on the soft tissue and it is routinely used in many types of surgery, but it is not known whether two steroids are better than one. The medications provided in this study are approved by the Food and Drug Administration (FDA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_3
Started Nov 2015
Typical duration for phase_3
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 13, 2015
CompletedFirst Submitted
Initial submission to the registry
October 5, 2017
CompletedFirst Posted
Study publicly available on registry
October 12, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 3, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2019
CompletedNovember 20, 2020
November 1, 2020
3.5 years
October 5, 2017
November 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative Pain
Change in Visual Analogue Scale Back and Leg score from preoperative value will be assessed
2 years postoperative
Secondary Outcomes (7)
Physical Functioning
2 years postoperative
Disability
2 years postoperative
General health status
2 years postoperative
Narcotic Consumption
1 week postoperative
Length of Stay
1 week postoperative
- +2 more secondary outcomes
Study Arms (2)
Local Depomedrol plus IV dexamethasone
ACTIVE COMPARATORLocal intraoperative application of methylprednisolone (Depomedrol) plus standard systemic (IV) dexamethasone
IV dexamethasone
PLACEBO COMPARATORStandard systemic (IV) dexamethasone only
Interventions
Application of 80mg Depomedrol (methylprednisolone acetate) suspension into the transforaminal space prior to incision closure
Administration of 10mg Dexamethasone IV intraoperatively
Eligibility Criteria
You may qualify if:
- Patients undergoing a primary 1- to 2-level MIS TLIF
- Diagnosis: myelopathy, radiculopathy, myeloradiculopathy, stenosis, herniated nucleus pulposus, degenerative disc disease, spondylosis, osteophytic complexes, and foraminal stenosis
- Patients able to provide informed consent
You may not qualify if:
- Allergies or other contraindications to medicines in the protocol including:
- (a) Existing history of gastrointestinal bleeding
- Current Smokers
- Lumbar spine trauma
- Bilateral cages
- Lack of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (6)
Schizas C, Tzinieris N, Tsiridis E, Kosmopoulos V. Minimally invasive versus open transforaminal lumbar interbody fusion: evaluating initial experience. Int Orthop. 2009 Dec;33(6):1683-8. doi: 10.1007/s00264-008-0687-8. Epub 2008 Nov 21.
PMID: 19023571BACKGROUNDMcGirt MJ, Parker SL, Lerner J, Engelhart L, Knight T, Wang MY. Comparative analysis of perioperative surgical site infection after minimally invasive versus open posterior/transforaminal lumbar interbody fusion: analysis of hospital billing and discharge data from 5170 patients. J Neurosurg Spine. 2011 Jun;14(6):771-8. doi: 10.3171/2011.1.SPINE10571. Epub 2011 Mar 18.
PMID: 21417699BACKGROUNDRanguis SC, Li D, Webster AC. Perioperative epidural steroids for lumbar spine surgery in degenerative spinal disease. A review. J Neurosurg Spine. 2010 Dec;13(6):745-57. doi: 10.3171/2010.6.SPINE09796.
PMID: 21121754BACKGROUNDJamjoom BA, Jamjoom AB. Efficacy of intraoperative epidural steroids in lumbar discectomy: a systematic review. BMC Musculoskelet Disord. 2014 May 5;15:146. doi: 10.1186/1471-2474-15-146.
PMID: 24885519BACKGROUNDDebi R, Halperin N, Mirovsky Y. Local application of steroids following lumbar discectomy. J Spinal Disord Tech. 2002 Aug;15(4):273-6. doi: 10.1097/00024720-200208000-00002.
PMID: 12177541BACKGROUNDHaws BE, Khechen B, Patel DV, Bawa MS, Ahn J, Bohl DD, Mayo BC, Massel DH, Guntin JA, Cardinal KL, Singh K. Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial. J Neurosurg Spine. 2018 Nov 9;30(2):222-227. doi: 10.3171/2018.7.SPINE18584. Print 2019 Feb 1.
PMID: 30497132DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kern Singh, MD
Rush University Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Department of Orthopaedic Surgery
Study Record Dates
First Submitted
October 5, 2017
First Posted
October 12, 2017
Study Start
November 13, 2015
Primary Completion
May 3, 2019
Study Completion
May 3, 2019
Last Updated
November 20, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share